Wyeth Hit With $1.5M Verdict In Prempro Case

Law360, New York (January 3, 2011, 3:37 PM EST) -- A federal jury has hit Pfizer Inc. unit Wyeth with $1.5 million in damages in a suit brought by a pharmacist who allegedly developed breast cancer through her use of menopause drug Prempro, marking the end of a recent string of favorable verdicts for the company in Prempro cases.

A jury in the U.S. District Court for the District of Puerto Rico said Thursday that Helen Rivera-Adams had proven she developed breast cancer because of her use of Prempro, and that Wyeth had failed to adequately...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.